REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 83 filers reported holding REPROS THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $9,000 | +125.0% | 13,551 | 0.0% | 0.00% | – |
Q3 2017 | $4,000 | -33.3% | 13,551 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | -62.5% | 13,551 | 0.0% | 0.00% | – |
Q1 2017 | $16,000 | -15.8% | 13,551 | 0.0% | 0.00% | – |
Q4 2016 | $19,000 | -34.5% | 13,551 | -2.2% | 0.00% | – |
Q3 2016 | $29,000 | +38.1% | 13,851 | 0.0% | 0.00% | – |
Q2 2016 | $21,000 | +61.5% | 13,851 | 0.0% | 0.00% | – |
Q1 2016 | $13,000 | -18.8% | 13,851 | 0.0% | 0.00% | – |
Q4 2015 | $16,000 | -84.5% | 13,851 | 0.0% | 0.00% | – |
Q3 2015 | $103,000 | -36.0% | 13,851 | -38.6% | 0.00% | – |
Q2 2015 | $161,000 | -94.8% | 22,551 | -93.8% | 0.00% | – |
Q1 2015 | $3,110,000 | -13.3% | 362,040 | +0.7% | 0.00% | – |
Q4 2014 | $3,588,000 | -66.8% | 359,459 | -67.1% | 0.00% | -100.0% |
Q3 2014 | $10,818,000 | -32.1% | 1,092,615 | +18.6% | 0.00% | -50.0% |
Q2 2014 | $15,937,000 | -17.3% | 921,128 | -15.2% | 0.00% | 0.0% |
Q1 2014 | $19,279,000 | -44.7% | 1,086,636 | -44.0% | 0.00% | 0.0% |
Q4 2013 | $34,854,000 | +73.9% | 1,940,063 | +159.5% | 0.00% | 0.0% |
Q3 2013 | $20,039,000 | +282.9% | 747,748 | +163.6% | 0.00% | +100.0% |
Q2 2013 | $5,234,000 | – | 283,652 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,132,367 | $8,096,000 | 1.86% |
DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,353,000 | 0.56% |
RTW INVESTMENTS, LP | 229,364 | $1,640,000 | 0.48% |
EDMOND DE ROTHSCHILD (SUISSE) S.A. | 182,500 | $1,305,000 | 0.41% |
GENERAL AMERICAN INVESTORS CO INC | 601,553 | $4,301,000 | 0.35% |
Baker Brothers Advisors | 1,955,944 | $13,985,000 | 0.12% |
CQS Cayman LP | 240,000 | $1,716,000 | 0.10% |
Gruss Capital Management LP | 304,000 | $2,174,000 | 0.08% |
J. Goldman & Co LP | 101,881 | $728,000 | 0.04% |
Squarepoint Ops LLC | 18,800 | $134,000 | 0.04% |